Metyrapone

Metyrapone
Clinical data
Trade names	Metopirone
AHFS/Drugs.com	Consumer Drug Information
Pregnancy; category	C US;
Routes of; administration	By mouth
ATC code	V04CD01 (WHO) ;
Pharmacokinetic data
Elimination half-life	1.9 ± 0.7 hours
Identifiers
	IUPAC name 2-methyl-1,2-di(pyridin-3-yl)propan-1-one;
CAS Number	54-36-4 ;
PubChem CID	4174;
IUPHAR/BPS	5224;
DrugBank	DB01011 ;
ChemSpider	4030 ;
UNII	ZS9KD92H6V;
KEGG	D00410 ;
ChEBI	CHEBI:44241 ;
ChEMBL	ChEMBL934 ;
CompTox Dashboard (EPA)	DTXSID1023314 ;
ECHA InfoCard	100.000.188
Chemical and physical data
Formula	C14H14N2O
Molar mass	226.279 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(c1cccnc1)C(c2cccnc2)(C)C;
	InChI InChI=1S/C14H14N2O/c1-14(2,12-6-4-8-16-10-12)13(17)11-5-3-7-15-9-11/h3-10H,1-2H3 ; Key:FJLBFSROUSIWMA-UHFFFAOYSA-N ;
	(verify)

Metyrapone, sold under the brand name Metopirone, is a medication which is used in the diagnosis of adrenal insufficiency and occasionally in the treatment of Cushing's syndrome (hypercortisolism). It is part of the steroidogenesis inhibitor class of drugs.